Revision history of "Development of globally innovative technology for the production of therapeutic antibodies based on bacterial expression systems, integrating stainless steel and single-use technologies" (Q78203)

12 October 2024

• curprev 21:3921:39, 12 October 2024‎ DG Regio talk contribs‎ 90,428 bytes +1‎ ‎Changed label, description and/or aliases in pt
• curprev 21:3921:39, 12 October 2024‎ DG Regio talk contribs‎ 90,427 bytes −192‎ ‎Set a claim value: summary (P836): O objectivo do projecto de I & D é desenvolver uma tecnologia globalmente inovadora para produzir um fragmento do anticorpo monoclonal produzido em células de E. coli utilizando tecnologia de ADN recombinante. O projecto pressupõe a implementação de trabalhos baseados em tecnologia inovadora para a produção de fragmentos de Mabs baseados em sistemas expressivos bacterianos. A aplicação dos resultados permitirá o lançamento de uma produção própria al...

22 March 2024

• curprev 13:1913:19, 22 March 2024‎ DG Regio talk contribs‎ 90,619 bytes +288‎ ‎Added qualifier: readability score (P590521): 0.5630470967377926

12 January 2024

• curprev 16:1316:13, 12 January 2024‎ DG Regio talk contribs‎ 90,331 bytes +1,083‎ ‎Changed an Item

14 June 2023

• curprev 18:2618:26, 14 June 2023‎ Admin talk contribs‎ 89,248 bytes 0‎ BatchIngestion

11 June 2023

• curprev 11:0611:06, 11 June 2023‎ Admin talk contribs‎ 89,248 bytes +435‎ BatchIngestion

24 May 2023

• curprev 16:5816:58, 24 May 2023‎ DG Regio talk contribs‎ 88,813 bytes +949‎ ‎Changed an Item

2 March 2023

• curprev 22:2222:22, 2 March 2023‎ DG Regio talk contribs‎ 87,864 bytes +4,797‎ ‎Changed label, description and/or aliases in da, sk, lv, it, et, bg, ga, ro, fi, sv, lt, nl, es, pt, sl, hu, fr, cs, de, el, hr, mt, and other parts

19 October 2022

• curprev 23:4223:42, 19 October 2022‎ DG Regio talk contribs‎ 83,067 bytes +1,211‎ ‎Changed an Item: Import item from Poland
• curprev 23:4223:42, 19 October 2022‎ DG Regio talk contribs‎ 81,856 bytes −418‎ ‎Removed claim: co-financing rate (P837): 40.0 percentage
• curprev 23:4223:42, 19 October 2022‎ DG Regio talk contribs‎ 82,274 bytes −411‎ ‎Removed claim: instance of (P35): Discontinued Kohesio Project (Q4412041)
• curprev 23:4223:42, 19 October 2022‎ DG Regio talk contribs‎ 82,685 bytes −5‎ ‎Changed an Item: Continued project

17 October 2022

• curprev 15:5015:50, 17 October 2022‎ DG Regio talk contribs‎ 82,690 bytes +416‎ ‎Changed an Item: Discontinued project

25 July 2022

• curprev 20:2320:23, 25 July 2022‎ DG Regio talk contribs‎ 82,274 bytes +52,085‎ ‎Changed label, description and/or aliases in da, el, hr, ro, sk, mt, pt, fi, sl, cs, lt, lv, bg, hu, ga, sv, et, nl, fr, de, it, es, and other parts: Adding translations: da, el, hr, ro, sk, mt, pt, fi, sl, cs, lt, lv, bg, hu, ga, sv, et,

19 January 2022

• curprev 11:1811:18, 19 January 2022‎ DG Regio talk contribs‎ 30,189 bytes +3,198‎ ‎Changed label, description and/or aliases in es, and other parts: Adding Spanish translations

15 January 2022

• curprev 22:2022:20, 15 January 2022‎ DG Regio talk contribs‎ 26,991 bytes +3,027‎ ‎Changed label, description and/or aliases in it, and other parts: Adding Italian translations

16 December 2021

• curprev 19:2319:23, 16 December 2021‎ DG Regio talk contribs‎ 23,964 bytes +3,156‎ ‎Changed label, description and/or aliases in nl, and other parts: Adding Dutch translations

7 December 2021

• curprev 08:2408:24, 7 December 2021‎ DG Regio talk contribs‎ 20,808 bytes +2,844‎ ‎Changed label, description and/or aliases in de, and other parts: Adding German translations

30 November 2021

• curprev 15:0315:03, 30 November 2021‎ DG Regio talk contribs‎ 17,964 bytes +2,769‎ ‎Created claim: summary (P836): L’objectif du projet de R & D est de développer une technologie innovante à l’échelle mondiale pour la production d’un fragment d’anticorps monoclonaux produit dans des cellules d’E.coli à l’aide de la technologie de l’ADN recombinant. Le projet a supposé la mise en œuvre de travaux basés sur des technologies innovantes pour la production de fragments MABS basés sur des systèmes expressifs bactériens. La mise en œuvre des résultats permettra le...
• curprev 15:0315:03, 30 November 2021‎ DG Regio talk contribs‎ 15,195 bytes +266‎ ‎Changed label, description and/or aliases in fr: translated_label

29 October 2020

• curprev 04:2404:24, 29 October 2020‎ DG Regio talk contribs‎ 14,929 bytes −406‎ ‎Removed claim: financed by (P890): Directorate-General for Regional and Urban Policy (Q8361), Removing unnecessary financed by statement
• curprev 04:2404:24, 29 October 2020‎ DG Regio talk contribs‎ 15,335 bytes −34‎ ‎Changed label, description and/or aliases in 2 languages: Changing unique label-description pair

14 October 2020

• curprev 11:3811:38, 14 October 2020‎ DG Regio talk contribs‎ 15,369 bytes +245‎ ‎Changed label, description and/or aliases in 1 language: translated_label
• curprev 11:3811:38, 14 October 2020‎ DG Regio talk contribs‎ 15,124 bytes −249‎ ‎Changed label, description and/or aliases in 1 language: remove_english_label
• curprev 11:3811:38, 14 October 2020‎ DG Regio talk contribs‎ 15,373 bytes +2,445‎ ‎Created claim: summary (P836): The aim of the R & D project is to develop a globally innovative technology to produce a fragment of the monoclonal antibody produced in E.coli cells using recombinant DNA technology. The project assumes the implementation of works based on innovative technology for the production of Mabs fragment based on bacterial expressive systems. Implementation of the results will allow the launch of highly efficient own production of the analysed protein...
• curprev 11:3811:38, 14 October 2020‎ DG Regio talk contribs‎ 12,928 bytes −1,800‎ ‎Removed claim: summary (P836): The objective of R & D is to develop a global innovative technology for the production of a fragment of the monoclonal antibody produced in the E.coli cells by using recombinant DNA technology.The project assumes the work of an innovative technology for the production of an MAB fragment based on bacterial express systems.The implementation of the results will allow for the launch of a high-efficient production of own tested protein fragments....

25 September 2020

• curprev 00:1300:13, 25 September 2020‎ DG Regio talk contribs‎ 14,728 bytes +1,160‎ ‎Changed an Item: Fixing rounding issue
• curprev 00:1300:13, 25 September 2020‎ DG Regio talk contribs‎ 13,568 bytes −1,162‎ ‎Removed claim: budget (P474): 4,071,017.9904 euro

23 September 2020

• curprev 03:0303:03, 23 September 2020‎ DG Regio talk contribs‎ 14,730 bytes +1,160‎ ‎Changed an Item: Fixing rounding issue
• curprev 03:0303:03, 23 September 2020‎ DG Regio talk contribs‎ 13,570 bytes −1,168‎ ‎Removed claim: EU contribution (P835): 1,628,407.1927999998 euro

15 July 2020

• curprev 19:0419:04, 15 July 2020‎ DG Regio talk contribs‎ 14,738 bytes +431‎ ‎Changed an Item

9 June 2020

• curprev 15:2915:29, 9 June 2020‎ DG Regio talk contribs‎ 14,307 bytes +429‎ ‎Changed an Item

6 June 2020

• curprev 21:1921:19, 6 June 2020‎ DG Regio talk contribs‎ 13,878 bytes +431‎ ‎Changed an Item

26 March 2020

• curprev 10:3010:30, 26 March 2020‎ DG Regio talk contribs‎ 13,447 bytes +431‎ ‎Changed an Item

4 March 2020

• curprev 09:0009:00, 4 March 2020‎ DG Regio talk contribs‎ 13,016 bytes +1,800‎ ‎Created claim: summary (P836): The objective of R & D is to develop a global innovative technology for the production of a fragment of the monoclonal antibody produced in the E.coli cells by using recombinant DNA technology.The project assumes the work of an innovative technology for the production of an MAB fragment based on bacterial express systems.The implementation of the results will allow for the launch of a high-efficient production of own tested protein fragments. th...

18 February 2020

• curprev 07:0707:07, 18 February 2020‎ DG Regio talk contribs‎ 11,216 bytes +249‎ ‎Changed an Item: Label in wikidata changed

8 February 2020

• curprev 16:0816:08, 8 February 2020‎ DG Regio talk contribs‎ 10,967 bytes +823‎ ‎Changed an Item
• curprev 16:0816:08, 8 February 2020‎ DG Regio talk contribs‎ 10,144 bytes −417‎ ‎Removed claim: financed by (P890): European Union (Q1)

31 January 2020

• curprev 16:0116:01, 31 January 2020‎ DG Regio talk contribs‎ 10,561 bytes +1,336‎ ‎Changed an Item
• curprev 16:0116:01, 31 January 2020‎ DG Regio talk contribs‎ 9,225 bytes −844‎ ‎Removed claims
• curprev 09:5009:50, 31 January 2020‎ DG Regio talk contribs‎ 10,069 bytes +844‎ ‎Changed an Item

13 January 2020

• curprev 21:0121:01, 13 January 2020‎ DG Regio talk contribs‎ 9,225 bytes +9,225‎ ‎Created a new Item